yourstate.us
Home / United States / 21 CFR
21 CFR 556.36

§ 556.36 Altrenogest.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 556.36, § 556.36 Altrenogest, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87733
Permanent ID
ys:prov:87733@1
SHA-256
f3c4f8fa610843d5e9fdab84e1863a5fb874613270751403cf62e8e8a6bbc5a2

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Acceptable daily intake (ADI). The ADI for total residue of altrenogest is 0.04 µg/kg of body weight per day. (b) Tolerances. The tolerances for altrenogest (marker residue) are: (1) Swine. (i) Liver (target tissue): 4 ppb. (ii) Muscle: 1 ppb. (2) [Reserved] (c) Related conditions of use. See § 520.48 of this chapter.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.